4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000076
COFO and Secretary sold 10,000 shares at an average $28.60 ($286,044)
- COFO and Secretary acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuth Alexander O. COFO and Secretary | 2023-05-15 | Option exercise | +10,000 | $5.28 | $52,800 | 538,691 | I: show line 1 in the form |
| Schuth Alexander O. COFO and Secretary | 2023-05-15 | Sale | −9,200 | $28.55 | $262,660 | 529,491 | I: show line 2 in the form |
| Schuth Alexander O. COFO and Secretary | 2023-05-15 | Sale | −800 | $29.23 | $23,384 | 528,691 | I: show line 3 in the form |
| Open-market sales · 10,000 sh · avg $28.60 · $286,044 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Schuth Alexander O. COFO and Secretary | 2023-05-15 | Option exercise · Stock Option (right to buy) | −10,000 | 78,937 | D: show line 4 in the form |
Loading xslF345X04/wf-form4_168435700588836.xml…